Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical Electronics

PUBLISHER: Grand View Research | PRODUCT CODE: 1869660

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1869660

Neurostimulation Devices Market Size, Share & Trends Analysis Report By Product, By Applications, By End Use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Neurostimulation Devices Market Summary

The global neurostimulation devices market size was estimated at USD 5.80 billion in 2024 and is projected to reach USD 13.93 billion by 2033, growing at a CAGR of 10.29% from 2025 to 2033. The growth of the market is attributed due to the rising prevalence of neurological disorders, growing preference for minimally invasive therapies, and increasing demand for long-term pain management solutions.

Technological advancements such as closed-loop stimulation, MRI-compatible devices, and improved battery life enhance treatment precision and patient outcomes, driving wider clinical acceptance. In addition, expanding applications of neurostimulation in conditions such as chronic pain, epilepsy, Parkinson's disease, depression, and spinal cord injuries, along with supportive reimbursement policies in many regions, are further accelerating market growth.

Growing government funding for neuroscience research is a key driver of the neurostimulation devices market, as it accelerates the development of advanced neurostimulation technologies and expands therapeutic applications. By allocating capital to research programs, clinical trials, and innovation initiatives, governments enable a deeper understanding of neurological disorders and support breakthroughs in treatment approaches using neurostimulation. This financial backing fosters collaboration among researchers, clinicians, and medical device developers and encourages the commercialization of next-generation systems with improved safety, precision, and patient outcomes. Furthermore, government initiatives aimed at enhancing healthcare accessibility and reducing the cost burden of neurological care indirectly promote the adoption of neurostimulation therapies, expanding their reach to a broader patient base and fueling overall market growth.

Global Neurostimulation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global neurostimulation devices market report on the basis of product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electrical Stimulation
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Parkinson's Disease
  • Chronic Pain
  • Migraine
  • Epilepsy
  • Tremor
  • Depression
  • Urinary & Fecal Incontinence
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Ambulatory Surgery Centers (ASC)
  • Clinics & Physiotherapy Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-066-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurostimulation Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Government funding for research and development
      • 3.2.1.2. Technological advancements in neurostimulation devices
      • 3.2.1.3. Increasing prevalence of neurological disorders
      • 3.2.1.4. Growing reimbursement coverage
      • 3.2.1.5. Expanding applications
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Complex regulatory framework
      • 3.2.2.2. Surgery-associated risk
  • 3.3. Neurostimulation Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Neurostimulation Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Neurostimulation Devices Market: Product Movement Analysis, 2024 & 2033 (USD Million)
  • 4.3. Global Neurostimulation Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Spinal Cord Stimulators
    • 4.4.1. Spinal cord stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Deep Brain Stimulators
    • 4.5.1. Deep brain stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Sacral Nerve Stimulators
    • 4.6.1. Sacral nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Vagus Nerve Stimulators
    • 4.7.1. Vagus nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Gastric Electrical Stimulation
    • 4.8.1. Gastric electrical stimulation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurostimulation Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Neurostimulation Devices Market: Application Movement Analysis, 2024 & 2033 (USD Million)
  • 5.3. Global Neurostimulation Devices Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
  • 5.4. Parkinson's Disease
    • 5.4.1. Parkinson's disease market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Chronic Pain
    • 5.5.1. Chronic pain market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Migraine
    • 5.6.1. Migraine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Epilepsy
    • 5.7.1. Epilepsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Tremor
    • 5.8.1. Tremor market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.9. Depression
    • 5.9.1. Depression market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.10. Urinary & Fecal Incontinence
    • 5.10.1. Urinary & fecal incontinence market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurostimulation Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Neurostimulation Devices Market: End use Movement Analysis, 2024 & 2033 (USD Million)
  • 6.3. Global Neurostimulation Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
  • 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
    • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Clinics & Physiotherapy Centers
    • 6.5.1. Clinics & physiotherapy centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurostimulation Devices Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. Reimbursement scenario
      • 7.3.2.5. U.S. neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Reimbursement scenario
      • 7.3.3.5. Canada neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Reimbursement scenario
      • 7.3.4.5. Mexico neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Reimbursement scenario
      • 7.4.2.5. UK neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Reimbursement scenario
      • 7.4.3.5. Germany neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Reimbursement scenario
      • 7.4.4.5. France neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Reimbursement scenario
      • 7.4.5.5. Italy neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Reimbursement scenario
      • 7.4.6.5. Spain neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Reimbursement scenario
      • 7.4.7.5. Sweden neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Reimbursement scenario
      • 7.4.8.5. Denmark neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Reimbursement scenario
      • 7.4.9.5. Norway neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. China neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Japan neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. India neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Reimbursement scenario
      • 7.5.5.5. South Korea neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. Australia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Thailand neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Brazil neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Argentina neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East and Africa
    • 7.7.1. Middle East and Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. South Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Saudi Arabia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. UAE neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Kuwait neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Abbott (St. Jude Medical)
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Medtronic
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Boston Scientific Corporation
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Aleva Neurotherapeutics
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Nexstim
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. LivaNova PLC
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Neuropace Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Nevro Corporation
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. electroCore, Inc.
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Axonics, Inc.
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Nalu Medical
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. Mainstay Medical
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Saluda Medical Pty Ltd
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. Biotronik
      • 8.5.20.1. Company overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic initiatives
    • 8.5.21. MicroTransponder Inc.
      • 8.5.21.1. Company overview
      • 8.5.21.2. Financial performance
      • 8.5.21.3. Product Benchmarking
      • 8.5.21.4. Strategic initiatives
    • 8.5.22. tVNS Technologies GmbH
      • 8.5.22.1. Company overview
      • 8.5.22.2. Financial performance
      • 8.5.22.3. Product Benchmarking
      • 8.5.22.4. Strategic initiatives
    • 8.5.23. Laborie
      • 8.5.23.1. Company overview
      • 8.5.23.2. Financial performance
      • 8.5.23.3. Product Benchmarking
      • 8.5.23.4. Strategic initiatives
Show more
Product Code: 978-1-68038-066-8

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 3 North America neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 4 North America neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 5 North America neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 6 U.S. neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 7 U.S. neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 8 U.S. neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 9 Canada neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 10 Canada neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 11 Canada neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 12 Mexico neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 13 Mexico neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 14 Mexico neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 15 Europe neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 16 Europe neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 17 Europe neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 18 Europe neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 19 Germany neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 20 Germany neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 21 Germany neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 22 UK neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 23 UK neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 24 UK neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 25 France neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 26 France neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 27 France neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 28 Italy neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 29 Italy neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 30 Italy neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 31 Spain neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 32 Spain neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 33 Spain neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 34 Denmark neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 35 Denmark neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 36 Denmark neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 37 Sweden neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 38 Sweden neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 39 Sweden neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 40 Norway neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 41 Norway neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 42 Norway neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 47 China neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 48 China neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 49 China neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 50 Japan neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 51 Japan neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 52 Japan neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 53 India neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 54 India neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 55 India neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 56 South Korea neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 57 South Korea neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 58 South Korea neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 59 Australia neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 60 Australia neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 61 Australia neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 62 Thailand neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 63 Thailand neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 64 Thailand neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 65 Latin America neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 66 Latin America neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 67 Latin America neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 68 Latin America neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 69 Brazil neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 70 Brazil neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 71 Brazil neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 72 Argentina neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 73 Argentina neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 74 Argentina neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 75 MEA neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 76 MEA neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 77 MEA neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 78 MEA neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 79 South Africa neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 80 South Africa neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 81 South Africa neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 85 UAE neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 86 UAE neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 87 UAE neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 88 Kuwait neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 89 Kuwait neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 90 Kuwait neurostimulation devices market, by end use 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neurostimulation devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Neurostimulation devices - market size and growth prospects (USD Million)
  • Fig. 11 Neurostimulation devices market: Industry Value Chain Analysis
  • Fig. 12 Neurostimulation devices market: Market Dynamics
  • Fig. 13 Neurostimulation devices market: PORTER's Analysis
  • Fig. 14 Neurostimulation devices market: PESTEL Analysis
  • Fig. 15 Neurostimulation devices market share by product, 2024 & 2033 (USD Million)
  • Fig. 16 Neurostimulation devices market, by product: market share, 2024 & 2033
  • Fig. 17 Spinal cord stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Deep brain stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Sacral nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Vagus nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Gastric electrical stimulation market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Neurostimulation devices market share by application, 2024 & 2033 (USD Million)
  • Fig. 24 Neurostimulation devices market, by application: market share, 2024 & 2033
  • Fig. 25 Parkinson's disease market share by application, 2024 & 2033 (USD Million)
  • Fig. 26 Chronic Pain market share by application, 2024 & 2033 (USD Million)
  • Fig. 27 Migraine market share by application, 2024 & 2033 (USD Million)
  • Fig. 28 Epilepsy market share by application, 2024 & 2033 (USD Million)
  • Fig. 29 Tremor market share by application, 2024 & 2033 (USD Million)
  • Fig. 30 Depression market share by application, 2024 & 2033 (USD Million)
  • Fig. 31 Neurostimulation devices market share by application, 2024 & 2033 (USD Million)
  • Fig. 32 Others market share by application, 2024 & 2033 (USD Million)
  • Fig. 33 Neurostimulation devices market share by end use, 2024 & 2033 (USD Million)
  • Fig. 34 Neurostimulation devices market, by end use: market share, 2024 & 2033
  • Fig. 35 Hospitals & Ambulatory Surgery Centers (ASC) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 Clinics & physiotherapy centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 37 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 Regional marketplace: key takeaways
  • Fig. 39 North America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 US neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Canada neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Europe neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 UK neurostimulation devices market estimates and forecasts, 2021 - 2033,) (USD Million)
  • Fig. 45 Germany neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 46 France neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 47 Italy neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 48 Spain neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 49 Sweden neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 50 Denmark neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 51 Norway neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 52 Asia Pacific neurostimulation devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 China neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Japan neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 India neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Australia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 MEA neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Saudi Arabia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 UAE neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Kuwait neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key company categorization
  • Fig. 68 Company market positioning
  • Fig. 69 Key company market share analysis, 2023
  • Fig. 70 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!